Structure-Based Vaccine & Antibody Discovery at AstraZeneca
Time: 9:45 am
day: Day 2
Details:
- Leveraging Cryo-EM in structure-based design of novel vaccine candidates
- Highlighting structural determination of MoA for neutralising antibodies against respiratory viruses
